It is misleading at best and disingenuous at worst to imply that cannabis smoke exposure is either equal to or more hazardous to health than tobacco smoking, or to imply that long-term data on its respiratory effects do not exist.
More than nine in ten pediatric oncology providers with opinions favor patients’ access to cannabis therapy, according to survey data provided this week at the 2016 annual meeting of the American Society of Clinical Oncology.
Marijuana smoke exposure is not positively associated with the development of cancers of the head or neck, according to the results of a systematic literature review published online ahead of print in the journal Archives of Oral Biology. “The result of this study indicated no association between lifetime marijuana use and the risk for development of head and neck cancer,” authors concluded.
NORML is pleased to present the latest expanded/updated edition of the publication Emerging Clinical Applications for Cannabis & Cannabinoids — a comprehensive review of the latest peer-reviewed science specific to the safety and therapeutic efficacy of whole-plant cannabis and/or its components.
Cannabis use is inversely associated with incidences of bladder cancer in males, according epidemiological findings published in the February issue of the journal Urology. “After adjusting for age, race or ethnicity, and body mass index, using tobacco only was associated with an increased risk of bladder cancer (hazard regression 1.52) whereas cannabis use was only associated with a 45 percent reduction in bladder cancer incidence (HR 0.55),” investigators reported.